Trials / Completed
CompletedNCT01162954
Phase I Study to Evaluate the Tolerability of Eye Drop DA-6034 in Healthy Volunteers
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Local Tolerability After Administration of Eye Drop DA-6034 in Healthy Volunteers(Phase I)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a double-blind, randomized, placebo-controlled, 4-period, cross-over clinical trial. The study is designed to evaluate the safety and local tolerability of DA-6034 upon single and repeated-dose topical application to the both eyes in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-6034 | |
| DRUG | Placebo |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2010-07-15
- Last updated
- 2014-10-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01162954. Inclusion in this directory is not an endorsement.